Kentucky recalls
3,504 federal recalls affecting Kentucky in the last 12 months - 141 Kentucky-specific plus 3,363 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-03-11FDA-DrugRising PharmaClass IINationwideStop using Rising Pharma Temozolomide capsules
Rising Pharmaceuticals is recalling specific bottles of Temozolomide 5mg capsules because testing found the medication didn't meet quality standards for purity and stability. The issue was discovered during routine 9-month stability testing. This affects 1,200 bottles distributed nationwide with expiration date 09/2026.
- 2026-03-11FDA-DrugThe Harvard DrugClass IINationwideCheck midodrine hydrochloride tablets for damaged packaging
Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.
- 2026-03-11FDA-DrugCiplaClass IIINationwideStop using Cipla Nilotinib capsules, Lot 5GJ0223
Cipla USA is recalling Nilotinib 200 mg capsules (Lot 5GJ0223, expiring 04/30/2027) because the capsules failed quality tests during stability testing. The capsules may not meet appearance and description standards, which means their safety and effectiveness cannot be guaranteed.
- 2026-03-11FDA-DrugCiplaClass IIINationwideStop using Cipla Nilotinib 150 mg capsules
Cipla USA is recalling specific lots of Nilotinib 150 mg capsules because testing found the capsules did not meet appearance and description standards after six months of storage. The affected lots are 5GJ0220, 5GJ0221, and 5GJ0222, with expiration date 04/30/2027. No injuries have been reported.
- 2026-03-11FDA-DrugHarbin Jixianglong BiotechClass IINationwideContact your pharmacy about semaglutide
The FDA is recalling semaglutide powder distributed by Harbin Jixianglong Biotech for compounding use only. The manufacturer did not complete required manufacturing process and bacterial endotoxin testing before shipping the product. This was a manufacturing oversight, not a confirmed safety incident.
- 2026-03-11FDA-DrugJixianglongClass IINationwideDo not use Harbin Jixianglong semaglutide
Harbin Jixianglong Biotech distributed semaglutide (an injectable medication for compounding) without completing required manufacturing process and bacterial endotoxin testing. This means the drug may not meet safety and purity standards. The affected lot is CP-030-20250711 with an expiration date of July 24, 2027.
- 2026-03-11FDA-DrugAcme UnitedClass IINationwideStop using ACME United hand wipes
ACME United Corporation's antimicrobial alcohol hand wipes (70% isopropyl alcohol) are being recalled because the manufacturer did not follow proper quality and safety procedures during production. Multiple lot numbers with expiration dates ranging from April 2027 to January 2028 are affected. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Children's Healthcare hand sanitizer wipes
The FDA identified manufacturing quality deviations (CGMP violations) in three lots of Children's Healthcare of Atlanta instant hand sanitizing wipes. These wipes may not meet quality and safety standards. The affected lots were distributed nationwide.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Dynarex BZK Antiseptic Towelettes
Dynarex BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) in 1000-packet boxes were manufactured with deviations from FDA quality standards. Affected lots are 53518 and 53519, with expiration dates of June 2027. The products were distributed nationwide.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Dynarex BZK Antiseptic Towelettes
Dynarex BZK Antiseptic Towelettes have been recalled because the manufacturer did not follow required quality and safety standards during production. The FDA identified manufacturing practice deviations that could affect product safety or effectiveness. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Green Guard Antiseptic Wipes
Green Guard Antiseptic Wipes have been recalled due to manufacturing quality control issues. The FDA found that these wipes did not meet proper manufacturing standards. This affects specific lots distributed nationwide.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Acme United hand sanitizing wipes
Acme United Corporation is recalling certain lots of hand sanitizing wipes due to manufacturing process deviations that do not meet federal standards. The affected wipes contain benzalkonium chloride 0.13% and were distributed nationwide. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using WP WipesPlus Hand Sanitizing Wipes
WP WipesPlus Hand Sanitizing Wipes (0.13% Benzalkonium Chloride) are being recalled due to manufacturing process deviations that do not meet FDA standards. The affected products were distributed nationwide. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Acme United Med-Nap Cleansing Towelettes
Acme United Corporation is recalling specific lots of Med-Nap Cleansing Towelettes because they were manufactured without following required quality and safety standards. The affected towelettes contain benzalkonium chloride and may not meet safety or sterility requirements.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using ACME Med-Nap cleansing towelettes
ACME United Corporation is recalling specific lots of Med-Nap cleansing towelettes (benzalkonium chloride 0.13%) due to manufacturing process deviations. The affected products may not meet quality and safety standards. Two lots are involved: MN15923 (expiring May 2028) and MN25822 (expiring August 2027).
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Dynarex Obstetrical Towelettes Cleanser
Dynarex Obstetrical Towelettes Cleanser with benzalkonium chloride 0.13% is being recalled because the manufacturer did not follow proper manufacturing practices during production. The affected product was distributed nationwide and may not meet quality and safety standards.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Wipes Plus hand sanitizing wipes
Wipes Plus hand sanitizing wipes have been recalled due to manufacturing quality control problems. The FDA found that the product did not meet required manufacturing standards. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using ACME BZK Antiseptic Towelettes
ACME United Corporation is recalling specific lots of BZK Antiseptic Towelettes due to manufacturing quality control problems. The affected towelettes may not meet safety and purity standards required for medical products.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Med Nap BZK Antiseptic Towelettes
Acme United Corporation is recalling Med Nap BZK Antiseptic Towelettes due to deviations from manufacturing standards that could affect product quality and safety. Multiple lot numbers distributed nationwide are affected. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Medi-First Antiseptic Wipes
Medi-First Antiseptic Wipes containing benzalkonium chloride were manufactured with deviations from FDA manufacturing standards. The affected wipes were distributed nationwide and may not meet quality and safety standards.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Savannah Antibacterial Towelettes
Savannah Antibacterial Towelettes have been recalled due to deviations from manufacturing quality standards (CGMP). The FDA found issues with how these products were made. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Max Packaging antibacterial towelettes
ACME United Corporation is recalling Max Packaging Antibacterial Towelettes (Benzalkonium Chloride 0.13%) due to manufacturing quality deviations. The recall affects specific lots distributed nationwide. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using recalled BZK Antiseptic Towelettes
ACME United Corporation is recalling multiple lots of BZK Antiseptic Towelettes (benzalkonium chloride 0.13%) due to manufacturing quality deviations. The towelettes were distributed nationwide under various brand names including Piedmont, Touchpoint, Wellstar Cobb, FSR, and Children's Healthcare of Atlanta labels.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using First Aid Only BZK Antiseptic Towelettes
First Aid Only BZK Antiseptic Towelettes have been recalled due to manufacturing quality deviations that do not meet FDA standards. Multiple lot numbers distributed nationwide are affected. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideCheck Dukal BZK Antiseptic Towelette lot numbers
Dukal BZK Antiseptic Towelettes were manufactured without meeting federal quality standards (CGMP deviations). Affected lots were distributed nationwide. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using First Aid Only BZK towelettes
First Aid Only BZK Antiseptic Towelettes (50-count packages) are being recalled because the manufacturer did not follow required quality and safety procedures during production. The recall affects specific lot numbers distributed nationwide. No injuries have been reported.
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using First Aid Only BZK Antiseptic Towelettes
First Aid Only BZK Antiseptic Towelettes have been recalled due to manufacturing quality control deviations. The FDA determined that certain lots did not meet required manufacturing standards. No injuries have been reported to date.
- 2026-03-11FDA-DrugTevaClass IINationwideStop using Teva metoprolol succinate 200 mg tablets
Teva Pharmaceuticals is recalling specific lots of metoprolol succinate extended-release 200 mg tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This could affect how well the blood pressure medication works. No injuries have been reported.
- 2026-03-11FDA-DrugTevaClass IINationwideStop taking Teva Metoprolol Succinate tablets
Teva Pharmaceuticals is recalling specific batches of Metoprolol Succinate Extended-Release 100 mg tablets because they may not dissolve properly in the body. This means the medication may not work as intended. The recall affects bottles with lot numbers ending in J251 or J252 and expiration dates of 12/2026.
- 2026-03-11FDA-DrugTevaClass IINationwideStop using Teva Metoprolol Succinate 50 mg tablets
Teva Pharmaceuticals is recalling certain batches of Metoprolol Succinate Extended-Release 50 mg tablets because they may not dissolve properly in the body, which could affect how well the medication works. The affected bottles have specific lot numbers and an expiration date of January 2027. No injuries have been reported.
Get notified about new Kentucky recalls
Free weekly digest. Add Kentucky to your profile to filter alerts to your state.